Antibacterial BOPA Film
Changsu antibacterial BOPA fim ne na kashe kwayoyin cuta wanda ke amfani da nauyin coulomb don tabbatar da tasirin maganin kashe kwayoyin cuta da ƙwayoyin cuta, ta haka ne ke lalata ma'aunin su na electrolyte, ta haka ne ke kashe ƙananan ƙwayoyin cuta saboda lalacewar bangon tantanin halitta, kuma a ƙarshe yana kawo ƙarin tsaro ga mabukaci.
●Yawan ƙwayoyin cuta ≥ 99.9%.
● Irin wannan aikin tare da BOPA na al'ada
●Kyawawan kaddarorin jijiyoyi
●Tasirin juriya, juriya mai huda, tauri mai kyau da kyakkyawan shinge
Changsu antibacterial BOPA SGS, wata hukumar gwaji ta kasa da kasa ce ta tabbatar da ita.
Hanyar Gwaji: GB/T 31402-2015 robobi-Aunawar ayyukan ƙwayoyin cuta akan saman filastik
| Gwajin kwayoyin halitta (s) | Escherichia coil ASaukewa: TCC8739 | Staphylococcus aureus ASaukewa: TCC6538P |
| Matsalolin kwayoyin cuta(CFU/mL) | 4.3×10^5 | 3.5×10^5 |
| vgwajin inoculum(mL) | 0.4 | 0.4 |
| U. | 3.99 | 3.92 |
| Ut | 5.54 | 5.92 |
| At | -0.20 | 2.66 |
| B (CFU/cm²) | 3.5×10^5 | 8.4×10^5 |
| C (CFU/cm²) | ＜0.63 | 4.6×10^2 |
| R | 5.7 | 3.3 |
| *Ayyukan rigakafi(%) | >99.9 | 99.9 |
Nau'in antibacterial na Changsu BOPA yana da kyakkyawan aikin antibacterial akan kwayoyin cutar gram-korau da kuma tabbataccen wakili na Escherichia coli da Staphylococcus aureus, kuma adadin ƙwayoyin cuta shine ≥ 99.9%.
| Kauri / μm | Nisa/mm | Magani | Maimaitawa | Bugawa |
| 15 | 300-2100 | korona guda/gefe biyu | ≤121℃ | ≤9 launuka |
Kayayyakin ruwa, sabbin abinci, cuku, kayan uwa da jarirai, da sauransu.
A halin yanzu, har yanzu akwai sarari a kasuwannin duniya don BOPA na ƙwayoyin cuta.Idan samfurin ya sami nasarar samar da yawa, zai sami aikace-aikacen da yawa a cikin kayan abinci kamar sabbin abinci, samfuran ruwa da yanki mai sanyi, da marufi don samfuran amfanin yau da kullun da marufi don masana'antar harhada magunguna.Musamman a ƙarƙashin tushen yaduwar COVID-19 da maimaitawa da haɓaka mahimmancin amincin abinci, BOPA na ƙwayoyin cuta za su ba da sabbin dama don mafi kyawun marufi don masana'antar abinci.
